Medullary thyroid carcinoma: a narrative historical review.
Calcitonin
Copp
carcinoma
discovery
medullary
thyroid
Journal
Expert review of anticancer therapy
ISSN: 1744-8328
Titre abrégé: Expert Rev Anticancer Ther
Pays: England
ID NLM: 101123358
Informations de publication
Date de publication:
08 2022
08 2022
Historique:
pubmed:
14
6
2022
medline:
6
8
2022
entrez:
13
6
2022
Statut:
ppublish
Résumé
Sporadic or hereditary medullary thyroid carcinoma (MTC) is an uncommon thyroid malignancy arising from calcitonin secreting parafollicular C cells. Interestingly, MTC and calcitonin were distinct entities that were discovered independently yet concurrently, and their association was unknown. This review aims to present a historical review of the evolution of our understanding of MTC and its tumor marker calcitonin to highlight the prominent individuals that influenced and shaped our knowledge of this uncommon thyroid cancer type up to the dawn of the 21 Surgery remains the cornerstone of treatment for localized MTC. However, several new treatment options are either available or in development for advanced or metastatic MTC, including several novel small molecules targeting oncogenic
Identifiants
pubmed: 35694971
doi: 10.1080/14737140.2022.2089118
doi:
Substances chimiques
Calcitonin
9007-12-9
Proto-Oncogene Proteins c-ret
EC 2.7.10.1
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM